Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Potential Role of Gum Arabic as Immunomodulator In Sudanese Rheumatoid Arthritis Patients

NCT02804581 is registered in ClinicalTrials.gov with Lamis Kaddam as lead sponsor.

NCT NCT02804581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02804581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Potential Role of Gum Arabic as Immunomodulator In Sudanese Rheumatoid Arthritis Patients
Lead sponsor
Lamis Kaddam
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2016
Completion date
October 31, 2016
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis